
|Videos|July 28, 2016
CINV: Understanding the Guidelines for Recommendations
Advertisement
Episodes in this series

James Natale, PharmD, BCOP, outlines the guidelines for acute and delayed emesis in patients receiving highly emetic chemotherapy versus moderately emetic chemotherapy.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
2
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
3
New CKD Outcome Set Tells Pharmacists What to Measure
4
GLP-1s and the HCM–Sleep Apnea–Obesity Connection
5













































































































